Scientific and Educational Presentations
Conn. 'experiment': Ultrasound keeps finding cancers in dense tissue
Supplemental ultrasound for dense breasts yields low PPV
Sunday, November 30 | 11:05 a.m.-11:15 a.m. | SSA01-03 | Arie Crown Theater
Four years after breast density notification legislation was enacted in Connecticut, the addition of screening breast ultrasound for women with dense tissue has continued to improve breast cancer detection compared with mammography alone, according to research to be presented on Sunday.
CT use during pregnancy has declined
Sunday, November 30 | 11:15 a.m.-11:25 a.m. | SSA01-04 | Arie Crown Theater
The positive predictive value (PPV) of screening ultrasound after mammography in women with dense breast tissue is low, which suggests that further studies are needed to identify those who really benefit from the exam, according to researchers from New York University.
How does PET/MR compare with PET/CT for breast cancer follow-up?
Sunday, November 30 | 11:35 a.m.-11:45 a.m. | SSA10-06 | Room E353B
CT use in pregnant women has declined 50% over the past four years, as awareness of the need to watch radiation dose has increased among patients and doctors, according to this presentation to be given on Sunday morning.
How well does PET/MR confirm cervical cancer treatment response?
Sunday, November 30 | 11:55 a.m.-12:05 p.m. | SSA12-08 | Room S504CD
How does whole-body PET/MR compare with PET/CT in terms of diagnostic performance for breast cancer treatment follow-up? Italian researchers will address this question during this Sunday morning scientific session.
Is it possible to avoid unnecessary follow-up after screening ultrasound?
Sunday, November 30 | 12:30 p.m.-1:00 p.m. | GUS102 | Lakeside Learning Center
How well does PET/MR correlate with response to treatment in women with advanced cervical cancer? Researchers from the University of North Carolina at Chapel Hill will address this question on Sunday.
Abridged breast MR protocol matches traditional exam
Sunday, November 30 | 1:00 p.m.-1:30 p.m. | BRS244 | Lakeside Learning Center
Is it possible to minimize unnecessary follow-up in women who have BI-RADS 3 lesions at screening ultrasound? Yes, according to research that will be presented in this Sunday poster session.
Breast MR helps track women with premenopausal cancer history
Monday, December 1 | 11:20 a.m.-11:30 a.m. | VSBR21-14 | Arie Crown Theater
An abridged breast MR protocol works just as well as a conventional exam, according to a study to be presented by researchers from New York University.
DBT plus FFDM and ultrasound improves diagnostic workup accuracy
Monday, December 1 | 11:30 a.m.-11:40 a.m. | VSBR21-15 | Arie Crown Theater
Breast MR is helpful for tracking women with a history of premenopausal breast cancer, which is especially important as these women are at increased risk for a second breast cancer diagnosis, according to a new study.
Tomo shows promise for preoperative evaluation
Monday, December 1 | 12:45 p.m.-1:15 p.m. | BRS254 | Lakeside Learning Center
Adding digital breast tomosynthesis (DBT) to full-field digital mammography (FFDM) and ultrasound improves the diagnostic accuracy of breast lesion workup, according to researchers from King's College Hospital in London.
DBT calls breast MR's staging role into question
Monday, December 1 | 3:10 p.m.-3:20 p.m. | SSE02-02 | Room E450A
Digital breast tomosynthesis shows promise for preoperatively identifying additional lesions in women newly diagnosed with breast cancer, according to this Monday afternoon presentation.
How does DBT affect BI-RADS 3 lesions?
Monday, December 1 | 3:20 p.m.-3:30 p.m. | SSE02-03 | Room E450A
How useful is MR in staging newly diagnosed breast cancer detected by digital breast tomosynthesis (DBT)? It's a question that needs to be considered, according to researchers from the University of Pennsylvania.
Breast thickness not density boosts radiation dose at DBT
Monday, December 1 | 3:30 p.m.-3:40 p.m. | SSE02-04 | Room E450A
Digital breast tomosynthesis (DBT) is rapidly becoming a key part of breast cancer diagnosis and will likely redefine BI-RADS criteria, particularly the BI-RADS 3 category of "probably benign lesions," according to researchers from Yale University.
Synthetic 2D for tomo performs comparably to conventional mammo
Tuesday, December 2 | 10:00 a.m.-10:10 a.m. | VSBR31-08 | Arie Crown Theater
Breast tissue thickness at compression should be considered with patients undergoing digital breast tomosynthesis (DBT), as it can contribute to higher radiation doses, according to this presentation to be given Tuesday morning.
Breast MRI rules out malignancy in BI-RADS 0 cases
Tuesday, December 2 | 11:00 a.m.-11:10 a.m. | VSBR31-12 | Arie Crown Theater
Synthetic 2D mammography used with digital breast tomosynthesis (DBT) performs just as well as conventional 2D mammography and DBT, which suggests that the technology can reduce women's radiation exposure, according to Italian researchers.
Are additional spot views after tomosynthesis necessary?
Tuesday, December 2 | 11:40 a.m.-11:50 a.m. | SSG01-08 | Room E451A
Breast MR reliably rules out malignancy in conventional BI-RADS 0 cases, researchers from Vienna have found.
Breast tissue complexity may predict false-positive recalls
Tuesday, December 2 | 11:50 a.m.-12:00 p.m. | VSBR31-17 | Arie Crown Theater
Tomosynthesis has been shown to reduce recalls from screening mammography and to be equivalent to or better than conventional spot views. So how necessary are additional spot tomosynthesis views when women have been recalled after screening? Researchers from Yale University will address this question during this Tuesday session.
Breast imaging method yields quantitative analysis
Tuesday, December 2 | 3:10 p.m.-3:20 p.m. | SSJ01-02 | Arie Crown Theater
In this presentation, researchers from the University of Pennsylvania will describe how computer-extracted breast tissue complexity features may be able to decrease false-positive recalls in screening mammography.
MRI phenotyping may help differentiate breast cancer subtypes
Tuesday, December 2 | 3:30 p.m.-3:40 p.m. | SSJ01-04 | Arie Crown Theater
Researchers have found that a dual-energy breast imaging technique may be able to decrease the number of unnecessary breast biopsies.
Does adding DBT to clinical practice reduce mammo recall rates?
Tuesday, December 2 | 3:50 p.m.-4:00 p.m. | SSJ01-06 | Arie Crown Theater
In this talk, researchers will describe how breast MRI computer-aided diagnosis technology and quantitative image analysis may be able to help characterize subtypes of breast cancer.
Breast US after negative mammo spot views causes more harm than good
Wednesday, December 3 | 12:15 p.m.-12:45 p.m. | BRS274 | Lakeside Learning Center
Screening recall rates for 2D digital mammography went down after digital breast tomosynthesis (DBT) was added into clinical practice, suggesting that DBT offers yet another benefit, according to research to be presented at this Wednesday poster session.
How well does BSGI-guided biopsy perform?
Wednesday, December 3 | 3:20 p.m.-3:30 p.m. | SSM01-03 | Arie Crown Theater
In this presentation, Canadian researchers will discuss how using breast ultrasound for further assessment after negative mammography spot views can cause more harm than good.
How aware are primary care physicians of breast density laws?
Wednesday, December 3 | 3:50 p.m.-4:00 p.m. | SSM02-06 | E451A
Breast biopsy guided by breast-specific gamma imaging (BSGI) is a viable method for biopsying lesions identified at BSGI but overlooked with mammography or ultrasound, according to this Wednesday afternoon presentation.
Ultrasound-guided transvaginal core biopsy safe for patients
Thursday, December 4 | 10:40 a.m.-10:50 a.m. | SSQ01-02 | Room E450A
How aware are primary care physicians of breast density notification laws? And if they aren't aware, how does that affect patient care? Researchers from the University of California, Davis plan to address these questions during this Thursday morning scientific session.
Thursday, December 4 | 11:30 a.m.-11:40 a.m. | SSQ10-07 | Room E450B
Ultrasound-guided transvaginal core biopsy is a reliable and safe procedure for diagnosing patients with pelvic masses, according to South Korean researchers.
Send your press release to email@example.com